HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

prostate-specific antigen (146-154)

used to induce specific T cell immunity for PSA

Also Known As:

PSA 146-154; PSA146-154

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Seminal Proteins: 8
    - Seminal Plasma Proteins: 25
      - Prostatic Secretory Proteins: 4
        Prostate-Specific Antigen: 15321
        prostate-specific antigen (146-154): 3
- Peptides: 82426
  - Peptide Fragments: 373
    - prostate-specific antigen (146-154): 3
Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Peptide Hydrolases: 23957
      - Serine Proteases: 3726
        Serine Endopeptidases: 11
        Kallikreins: 2114
        Prostate-Specific Antigen: 15321
        prostate-specific antigen (146-154): 3
      - Endopeptidases: 633
        Serine Endopeptidases: 11
        Kallikreins: 2114
        Prostate-Specific Antigen: 15321
        prostate-specific antigen (146-154): 3
Biological Factors: 2472
- Biomarkers: 240291
  - Tumor Biomarkers: 15272
    - Prostate-Specific Antigen: 15321
      - prostate-specific antigen (146-154): 3
- Antigens: 143924
  - Neoplasm Antigens: 6217
    - Prostate-Specific Antigen: 15321
      - prostate-specific antigen (146-154): 3

Experts

1.	Peace, David J: 2 articles (01/2010 - 09/2006)
2.	Perambakam, Supriya: 2 articles (01/2010 - 09/2006)
3.	Edassery, Seby: 1 article (01/2010)
4.	Xie, Hui: 1 article (01/2010)
5.	Bressler, Linda: 1 article (09/2006)
6.	DeChristopher, Phillip: 1 article (09/2006)
7.	Hallmeyer, Sigrun: 1 article (09/2006)
8.	Mahmud, Delores: 1 article (09/2006)
9.	Mahmud, Nadim: 1 article (09/2006)
10.	Nunez, Rafael: 1 article (09/2006)

Related Diseases

1.

Prostatic Neoplasms (Prostate Cancer)

09/01/2006 - "Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide."
02/01/1997 - "A large portion of patients with prostate cancer express the HLA-A2 phenotype, implying that many prostate cancers might be targeted by HLA-A2-restricted CTL with specificity for the PSA 146-154 epitope."
01/01/2010 - "Twenty-eight HLA-A2+ patients with high-risk, locally advanced or metastatic, hormone-sensitive prostate cancer were immunized with a peptide homologue of prostate-specific antigen, PSA146-154, between July 2002 and September 2004 and monitored for clinical and immune responses. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Prostate-Specific Antigen (Semenogelase)
3.	HLA-A2 Antigen (HLA A2 Antigen)
4.	Hormones (Hormone)
5.	Epitopes